Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A15999 | 28620012 | Clin Sci (Lond) | Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes. | 2017 | Details |
| A16002 | 28618991 | Curr Med Chem | Effects of Polyphenolic Derivatives on Heme Oxygenase-System in Metabolic Dysfunctions. | 2018 | Details |
| A16012 | 28612285 | J Endocrinol Invest | Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis. | 2017 | Details |
| A16021 | 28606575 | Nutrition | Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: The results of an Italian Study. | 2017 | Details |
| A16030 | 28600319 | Physiol Genomics | Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification. | 2017 | Details |
| A16031 | 28600126 | Exp Mol Pathol | Chemokine (CC-motif) receptor-like 2 mRNA is expressed in hepatic stellate cells and is positively associated with characteristics of non-alcoholic steatohepatitis in mice and men. | 2017 | Details |
| A16045 | 28595552 | Curr Med Chem | Pigment Epithelium-Derived Factor: A Novel Therapeutic Target for Cardiometabolic Diseases and Related Complications. | 2018 | Details |
| A16057 | 28591070 | J Clin Gastroenterol | Emerging Gastrointestinal and Liver Diseases in Asia Pacific: Implications to Health Care in the Region (World Gastroenterology Organization: Asian Pacific Association of Gastroenterology Distinguished Global Lecture 2015). | 2017 | Details |
| A16063 | 28587078 | Nutrients | Morinda citrifolia Linn. (Noni) and Its Potential in Obesity-Related Metabolic Dysfunction. | 2017 | Details |
| A16074 | 28585204 | Adv Exp Med Biol | Insulin Resistance, Obesity and Lipotoxicity. | 2017 | Details |
| A16076 | 28581362 | Future Cardiol | PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ. | 2017 | Details |
| A16081 | 28579536 | Gastroenterology | Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity. | 2017 | Details |
| A16088 | 28577304 | Int J Cancer | The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort. | 2017 | Details |
| A16092 | 28575232 | J Clin Endocrinol Metab | Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial. | 2017 | Details |
| A16103 | 28570615 | PLoS One | Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage. | 2017 | Details |
| A16107 | 28566439 | Eur J Endocrinol | MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease. | 2017 | Details |
| A16120 | 28554682 | Clin Gastroenterol Hepatol | Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity. | 2017 | Details |
| A16121 | 28552096 | Dan Med J | The role of incretin hormones and glucagon in patients with liver disease. | 2017 | Details |
| A16133 | 28545373 | Curr Med Chem | Modulation of Aquaporins by Dietary Patterns and Plant Bioactive Compounds. | 2019 | Details |
| A16134 | 28545368 | Curr Med Chem | Improving Metabolic Control Through Functional Foods. | 2019 | Details |
| A16138 | 28544245 | Diabetes Obes Metab | Ghrelin receptor inverse agonists as a novel therapeutic approach against obesity-related metabolic disease. | 2017 | Details |
| A16154 | 28534852 | Nutrients | Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies. | 2017 | Details |
| A16164 | 28529199 | J Clin Res Pediatr Endocrinol | Can Fetuin-A Be a Marker for Insulin Resistance and Poor Glycemic Control in Children with Type 1 Diabetes Mellitus? | 2017 | Details |
| A16172 | 28524171 | Nat Rev Endocrinol | Endocrine-disrupting chemicals and fatty liver disease. | 2017 | Details |
| A16175 | 28521870 | Metabolism | The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. | 2017 | Details |
| A16185 | 28512251 | Mol Cancer Res | Inhibition of the Cell Death Pathway in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocarcinogenesis Is Associated with Histone H4 lysine 16 Deacetylation. | 2017 | Details |
| A16188 | 28511199 | Inflamm Bowel Dis | Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel Disease. | 2017 | Details |
| A16190 | 28511163 | Wiad Lek | [Impact of physical activity on anthropometric indices in patients with nonalcoholic fatty liver disease and pre-diabetes or type 2 diabetes]. | 2017 | Details |
| A16191 | 28511161 | Wiad Lek | [The diagnostics and clinical pattern of nonalcoholic fatty liver disease in patients with pre-diabetes and type 2 diabetes and obesity]. | 2017 | Details |
| A16192 | 28511152 | Wiad Lek | [Pathogenetic substantiation of complex treatment of nonalcoholic steatohepatitis and steatosis in patients with pre-diabetes and type 2 diabetes]. | 2017 | Details |
| A16196 | 28509327 | Int J Cancer | The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease. | 2017 | Details |
| A16204 | 28507343 | Sci Rep | Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice. | 2017 | Details |
| A16222 | 28502444 | Pediatr Clin North Am | Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications. | 2017 | Details |
| A16228 | 28498022 | Curr Med Res Opin | Thyroid hormone analogs for the treatment of dyslipidemia: past, present, and future. | 2017 | Details |
| A16240 | 28489307 | Liver Int | Non-alcoholic fatty liver and advanced fibrosis in the elderly: Results from a community-based Polish survey. | 2017 | Details |
| A16266 | 28479500 | Clin Gastroenterol Hepatol | Histologic Scores for Fat and Fibrosis Associate With Development of Type 2 Diabetes in Patients With Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16284 | 28471821 | Eur J Gastroenterol Hepatol | Diabetic status and grade of nonalcoholic fatty liver disease are associated with lower baroreceptor sensitivity in patients with nonalcoholic fatty liver disease. | 2017 | Details |
| A16288 | 28470881 | Aliment Pharmacol Ther | Concentration-dependent response to pioglitazone in nonalcoholic steatohepatitis. | 2017 | Details |
| A16295 | 28469366 | Ann Gastroenterol | Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markers. | 2017 | Details |
| A16300 | 28468951 | Clin Sci (Lond) | Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease. | 2017 | Details |
| A16301 | 28468933 | J Endocrinol | The metabolic syndrome in mice overexpressing neuropeptide Y in noradrenergic neurons. | 2017 | Details |
| A16313 | 28464337 | J Gastroenterol Hepatol | Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes. | 2018 | Details |
| A16331 | 28455679 | Curr Obes Rep | Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over. | 2017 | Details |
| A16345 | 28445310 | Medicine (Baltimore) | Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy. | 2017 | Details |
| A16356 | 28441459 | PLoS One | Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study. | 2017 | Details |
| A16358 | 28439482 | Cureus | Association of Non-alcoholic Fatty Liver Disease with Conduction Defects on Electrocardiogram. | 2017 | Details |
| A16370 | 28432400 | Internist (Berl) | [The intestinal microbiome and metabolic diseases : From obesity to diabetes and nonalcoholic steatohepatitis]. | 2017 | Details |
| A16371 | 28431668 | Diabetes Metab | GLP-1 receptor agonists in NAFLD. | 2017 | Details |
| A16375 | 28429199 | Curr Gastroenterol Rep | Gastric Bypass and Influence on Improvement of NAFLD. | 2017 | Details |
| A16376 | 28428634 | Nat Rev Gastroenterol Hepatol | Lipid droplets and liver disease: from basic biology to clinical implications. | 2017 | Details |
| A16401 | 28417532 | Diabetes Obes Metab | Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes. | 2017 | Details |
| A16433 | 28392404 | Prog Lipid Res | A global perspective on FOXO1 in lipid metabolism and lipid-related diseases. | 2017 | Details |
| A16434 | 28392354 | Diabetes Metab Syndr | Lower circulating irisin is associated with nonalcoholic fatty liver disease and type 2 diabetes. | 2017 | Details |
| A16436 | 28389566 | J Biol Chem | Microbial metabolites in health and disease: Navigating the unknown in search of function. | 2017 | Details |
| A16437 | 28389414 | Cell Signal | Niclosamide: Beyond an antihelminthic drug. | 2017 | Details |
| A16448 | 28381741 | Intern Med | Non-alcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-aged Japanese Men and Women. | 2017 | Details |
| A16449 | 28381740 | Intern Med | The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD). | 2017 | Details |
| A16451 | 28381382 | Hepatobiliary Pancreat Dis Int | The association of non-alcoholic fatty liver disease and metabolic syndrome in a Chinese population. | 2017 | Details |
| A16453 | 28377802 | Ann Med Surg (Lond) | An observational study on the association of nonalcoholic fatty liver disease and metabolic syndrome with gall stone disease requiring cholecystectomy. | 2017 | Details |
| A16464 | 28372259 | Biomed Pharmacother | Medicinal plants and phytochemicals with anti-obesogenic potentials: A review. | 2017 | Details |
| A16465 | 28371475 | J Diabetes Investig | Impact of non-alcoholic fatty pancreas disease on glucose metabolism. | 2017 | Details |
| A16473 | 28368286 | J Clin Invest | Distinct but complementary contributions of PPAR isotypes to energy homeostasis. | 2017 | Details |
| A16478 | 28365312 | J Hepatol | Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis. | 2017 | Details |
| A16488 | 28358980 | Cochrane Database Syst Rev | Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis. | 2017 | Details |
| A16489 | 28358620 | Metab Syndr Relat Disord | Daily Coffee Intake Inhibits Pancreatic Beta Cell Damage and Nonalcoholic Steatohepatitis in a Mouse Model of Spontaneous Metabolic Syndrome, Tsumura-Suzuki Obese Diabetic Mice. | 2017 | Details |
| A16501 | 28350839 | PLoS One | Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study. | 2017 | Details |
| A16512 | 28346567 | J Nutr Health Aging | Effect of a Low Glycemic Index Mediterranean Diet on Non-Alcoholic Fatty Liver Disease. A Randomized Controlled Clinici Trial. | 2017 | Details |
| A16522 | 28340509 | Liver Transpl | Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma. | 2017 | Details |
| A16529 | 28334911 | Hum Mol Genet | MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat. | 2017 | Details |
| A16533 | 28332301 | J Diabetes | Randomized trial comparing the effects of gliclazide, liraglutide, and metformin on diabetes with non-alcoholic fatty liver disease. | 2017 | Details |
| A16534 | 28330852 | FASEB J | A controlled-release mitochondrial protonophore reverses hypertriglyceridemia, nonalcoholic steatohepatitis, and diabetes in lipodystrophic mice. | 2017 | Details |
| A16539 | 28325853 | Diabetes | Deletion of Macrophage Mineralocorticoid Receptor Protects Hepatic Steatosis and Insulin Resistance Through ERα/HGF/Met Pathway. | 2017 | Details |
| A16541 | 28325476 | Arab J Gastroenterol | Erectile dysfunction in patients with nonalcoholic fatty liver disease. | 2017 | Details |
| A16543 | 28324110 | J Clin Endocrinol Metab | Effects of Metreleptin in Pediatric Patients With Lipodystrophy. | 2017 | Details |
| A16544 | 28324002 | J Clin Endocrinol Metab | Association of NAFLD With Diabetes and the Impact of BMI Changes: A 5-Year Cohort Study Based on 18,507 Elderly. | 2017 | Details |
| A16545 | 28323952 | J Clin Endocrinol Metab | Randomized Controlled Trial of a MUFA or Fiber-Rich Diet on Hepatic Fat in Prediabetes. | 2017 | Details |
| A16554 | 28319060 | Oncogene | The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis. | 2017 | Details |
| A16562 | 28315901 | Med Sci Monit | The Effect of Sitagliptin on Lipid Metabolism of Fatty Liver Mice and Related Mechanisms. | 2017 | Details |
| A16563 | 28314735 | Gut | Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. | 2017 | Details |
| A16583 | 28297798 | Zhonghua Gan Zang Bing Za Zhi | [Treatment of non-alcoholic fatty liver disease: an interpretation of the European clinical guidelines for obesity, type 2 diabetes, and digestive disease]. | 2017 | Details |
| A16586 | 28297791 | Zhonghua Gan Zang Bing Za Zhi | [Research on the natural history of non-alcoholic fatty liver disease should be taken seriously]. | 2017 | Details |
| A16590 | 28296249 | J Dig Dis | Association between non-invasively diagnosed hepatic steatosis and chronic kidney disease in Chinese adults on their health check-up. | 2017 | Details |
| A16592 | 28294515 | Liver Int | Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score). | 2017 | Details |
| A16597 | 28293086 | World J Gastroenterol | Impact of smoking habit on surgical outcomes in non-B non-C patients with curative resection for hepatocellular carcinoma. | 2017 | Details |
| A16598 | 28291240 | Am J Gastroenterol | Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife. | 2017 | Details |
| A16600 | 28290049 | Curr Diab Rep | Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis. | 2017 | Details |
| A16613 | 28283346 | Eur J Intern Med | Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes? | 2017 | Details |
| A16616 | 28281517 | Ter Arkh | [Diabetes mellitus and nonalcoholic fatty liver disease: The verges of contingency]. | 2017 | Details |
| A16628 | 28276774 | Expert Rev Clin Pharmacol | Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetes. | 2017 | Details |
| A16638 | 28271032 | Mol Metab | Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice. | 2017 | Details |
| A16659 | 28260070 | Int J Mol Med | A long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, as a preventive drug for the development of hepatic steatosis in high-fructose diet-fed ob/ob mice. | 2017 | Details |
| A16666 | 28256088 | Diabetes Obes Metab | Prevalence of elevated liver enzymes in adults with type 1 diabetes: A multicentre analysis of the German/Austrian DPV database. | 2017 | Details |
| A16670 | 28254449 | J Diabetes Complications | Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes. | 2017 | Details |
| A16692 | 28241279 | JAMA Intern Med | Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis: A Meta-analysis. | 2017 | Details |
| A16718 | 28224373 | J Gen Intern Med | Drug-Induced Liver Injury in the Setting of Glycogenic Hepatopathy. | 2017 | Details |
| A16722 | 28223446 | Diabetes Care | Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action. | 2017 | Details |
| A16724 | 28222828 | Nutr Res Rev | Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. | 2017 | Details |
| A16726 | 28220621 | J Diabetes | Low prevalence of non-alcoholic fatty liver disease in patients with type 1 diabetes is associated with decreased subclinical cardiovascular disease. | 2017 | Details |
| A16733 | 28218263 | Nat Rev Nephrol | Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. | 2017 | Details |
| A16738 | 28215516 | Dig Liver Dis | AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. | 2017 | Details |